AntimicrobialResearch Phase

Alpha-Defensin 5

Oral, Topical

Overview

Alpha-defensin 5 (HD5) is a 32-amino acid cationic peptide predominantly expressed by Paneth cells in the small intestinal crypts. It contains three disulfide bonds that stabilize its beta-sheet structure and enable membrane disruption of bacteria, fungi, and some viruses.

Mechanism of Action

HD5 plays a critical role in maintaining intestinal homeostasis by regulating gut microbiota composition and protecting the epithelial barrier. Altered HD5 expression has been implicated in inflammatory bowel disease, necrotizing enterocolitis, and susceptibility to enteric infections..

Research Summary & Key Findings

Preclinical studies have demonstrated that HD5 deficiency in mouse models increases susceptibility to intestinal pathogens and dysbiosis. Observational human studies have correlated reduced HD5 expression with Crohn disease severity and neonatal gut inflammation. Therapeutic strategies to augment HD5 expression or deliver recombinant peptide remain in early research stages with no clinical trials reported.

Clinical Status

Research Phase

Alpha-Defensin 5 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

OralTopical

Related Peptides in Antimicrobial

Find a Provider

Find a verified provider who offers Alpha-Defensin 5 therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Alpha-Defensin 5.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.